Supporting people in hospitals across South Australia through vital health and medical research and improved patient care.
Meet our passionate and dedicated team.
Meet our Board and Governance team.
THRF adopts extremely high transparency standards when reporting our financials.
Supports research into the detection, management & treatment of breast cancer.
Funding research into prostate cancer prevention, detection & treatment.
Improving heart health through advances in knowledge & research to beat heart disease.
Our aim is to reduce & eliminate the high incidence of chronic kidney disease and diabetes.
Supports health and wellbeing research & programs for veterans, emergency service personnel and their families.
Driving collaboration, innovation & research to develop best-practice arts, design & health programs.
Supporting world-class stroke research to improve prevention, diagnosis & acute treatment to cure stroke.
Providing donor stool to treat patients with bowel conditions and foster research into faecal transplant as a treatment.
Do you want to join our team? Check out current career opportunities here.
View some of the commonly asked questions about our organisation.
We are so grateful to those who donate their time and skills to support life-changing medical research. Find out more…
Get in touch with us here.
Scientists working tirelessly in the lab of the Centre for Cancer Biology have identified that high levels of a protein (called quaking) plays a key role in the bad prognosis of prostate cancer tumours that have become resistant to chemotherapy and other treatments.
They have also found this protein is higher in patients with prostate cancer that goes on to spread to other parts of the body, becoming more difficult to treat.
“We’ve made really good progress in our research since securing funding earlier in 2018,” Dr Gregory explained.
“We screened a very large cohort of prostate cancer patients, in collaboration with colleagues in Canada, finding exactly what we had hoped – that high levels of this protein do indeed correlate with a bad prognosis for prostate cancer and the spread of this disease.
“This now means we can start our work in developing models where we can manipulate this protein and look at its effect on cancer cells in the hope to lead to new treatments for aggressive, hard to treat prostate cancer.”
We look forward to updating you on the next phase of this research in 2019!
support the centre for cancer biology